Mebutamate

DB06797ApprovedSmall molecule

Mebutamate is a sedative and anxiolytic drug with anti-hypertensive (blood pressure lowering) effects comparable to those of other barbiturates but is only around 1/3rd the potency of secobarbital as a... Side effects include dizziness and headaches.

Chemical structure of Mebutamate
Formula / weight
C10H20N2O4 · 232.2768 g/mol (avg)
Also known as
Dicamoylmethtane
Code names
BRN 1788226 · W-583

Resolves to

Compound
UNII5H8F175RERCAS64-55-1ChEMBLCHEMBL1200922ChEBI31804KEGGD01807
Clinical / RWD
ATCN05BC04
Structure
InChIKeyLEROTMJVBFSIMP-UHFFFAOYSA-NSMILESCCC(C)C(C)(COC(N)=O)COC(N)=O
Targets
Q99928GABRG3

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
666Drug interactionsStructured to mechanism, not free text
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Mebutamate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In